Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2006
  2. Published

    Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma

    Brasso, K., Christensen, I. J., Johansen, Julia Sidenius, Teisner, B., Garnero, P., Price, P. A. & Iversen, P., 1 Apr 2006, In: Prostate. 66, 5, p. 503-13 11 p.

    Research output: Contribution to journal › Journal article › Research

  3. Published

    YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

    Rathcke, C. N., Johansen, Julia Sidenius & Vestergaard, H., Feb 2006, In: Inflammation Research. 55, 2, p. 53-9 7 p.

    Research output: Contribution to journal › Journal article › Research

  4. Published

    Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

    Schmidt, H., Johansen, Julia Sidenius, Gehl, Julie, Geertsen, P. F., Fode, K. & von der Maase, H., 2006, In: Cancer. 106, 5, p. 1130-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma

    Schmidt, H., Johansen, Julia Sidenius, Sjoegren, P., Christensen, I. J., Sorensen, B. S., Fode, K., Larsen, J. & von der Maase, H., 2006, In: Journal of Clinical Oncology. 24, 5, p. 798-804 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 13762833